Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-25
1996-08-27
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548253, C07D25704, A61K 3141
Patent
active
RE0353213
ABSTRACT:
A tetrazoleacetic acid derivative represented by the following general formula (I): ##STR1## [[in Formula (I),] wherein R.sub.1 represents a hydrogen atom or an alkyl group; R.sub.2 represents a hydrogen atom, an alkyl group, an aralkyl group, a halogen atom, a haloalkyl group, a hydroxyl group, an alkoxy group, an alkoxyalkyl group, an amino group, an aryl group, an alkyl or aryl thio group, an alkyl or aryl carbonylamino group, an alkyl or aryl sulfonylamino group, an alkyl or aryl aminosulfonyl group, an alkyl or aryl sulfonyl group or an alkyl or aryl sulfinyl group; and X represents --O-- or --S--[]] except for [5-(2-thienyl)tetrazol-1-yl] acetic acid, [5-(2-furyl)tetrazol-1-yl) acetic acid, (5-(5-bromo-2-furyl)tetrazol-1-yl)acetic acid, (5-(5-phenylthio-2-furyl)tetrazol-1-yl)acetic acid, (5-(5-phenylsulfonyl-2-furyl)tetrazol-1-yl)acetic acid and ethyl esters thereof, or a salt thereof shows excellent aldose reductase inhibitory activity, has low toxicity to organisms and is quite effective as an essential component of a preventative medicine and/or remedy for diabetic complications.
REFERENCES:
patent: 4886885 (1989-12-01), Baker et al.
Chem. Abstract 106:84617z, 1987.
Chem. Abstract 106:33069q, 1987.
Chem. Abstract 109:37780z, 1988.
Chem. Abstract 111:77925y, 1989.
Chem. Abstract 111:57646e, 1989.
Robert T. Buckler et al, Synthesis and Antiinflammatory Activity of some Aryltetrazolyalkanoic Acids. J. Med. Chem. 13:725-729. 1970.
C. R. Jacobson and E. D. Amstutz, Studies in Tetrazole Chemistry, IV. Tetrazolylacenic Acids and Esters. J. Org. Chem. 21:311-315. 1955.
R. Rapp and J. Howard, Tetrazolylacetic acids, Can. J. Chem. 47:813-819. 1969.
Fred Einberg, Alkylation of 5-Substituted Tetrazoles with a --Chlorocarbonyl Compounds, J. Org. Chem. 35:3978-3980. 1970.
L'ubomir Janda et al., Semisynthetic Cephalosporines, the Synthesis of Some Substituted Tetrazolylacetic Acids, Cll Czech Chem Commun 49:1505-1514. 1984.
L'ubomir Janda et al, Semisynthetic Cephalosporines, Synthesis of Some Substituted Tetrazolyl Acetic and Propionic Acids. Coll. Czech. Chem. Commun. 49:1699-1713. 1984.
L. Janda and Z. Voticky, Synthesis of Some Substituted Tetrazolylacetic Acids and the Corresponding 3-substituted Propionic Acids. Acta. Chem. Scand. 26:541-548. 1972.
G. Szeimies et al., Synthese und Thermeisches Verhalten Ciniger 3-Aryl-3-Axido-Aziridin-2-Carbonsaure-Ethylester, Chem. Ber. 110:2922-2938. 1977.
V. S. Poplavskii et al., Tetrazoles Zhumai organicheskoi khimii. 1982. XVIII. No. 9. 1977. 1981-85.
A. K. Sorensen et al., Syntheses of Some New Tetrazolylacetic Acids and the Corresponding 3-Substituted Propionic Acids, Acta Chem. Scand.26:541-548 (1972).
G. Szeimies et al., Synthese und Thermisches Verhalten Ciniger 3-Aryl-3-Azido-Aziridin-2-Carbonsaure--Ethylester, Chem. Ber. 110:2922-2938 (1977).
V. S. Poplavskii et al., Tetrazoles Zhurnal organicheskoi khimii, 1982, XVIII, No. 9, 1981-1985.
Agata Mitsuzi
Goto Masayoshi
Horio Yoshihiro
Inukai Sinji
Ootake Yasuhiro
Springer David B.
Wakamoto Pharmaceutical Co., Ltd.
LandOfFree
Tetrazoleacetic acid derivatives having aldose reductase inhibit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrazoleacetic acid derivatives having aldose reductase inhibit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrazoleacetic acid derivatives having aldose reductase inhibit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048151